Drugs Made In America Acquisition II Corp. Ordinary Shares Working Capital to Net Assets Ratio
Drugs Made In America Acquisition II Corp. Ordinary Shares working capital to net assets ratio. Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Working Capital to Net Assets ratio of -0.1% as of June 2026. Working capital of $-426.75K (current assets of $217.82K minus current liabilities of $644.57K) is measured against net assets of $495.96 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check DMII tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
Working capital to net assets ratio of Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025. This chart shows how Drugs Made In America Acquisition II Corp. Ordinary Shares's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at -0.1%, reflecting working capital of $-426.75K against net assets of $495.96 Million USD. See Drugs Made In America Acquisition II Cor (DMII) defensive interval to measure how many days the company can operate on defensive assets alone.
Drugs Made In America Acquisition II Corp. Ordinary Shares Working Capital to Net Assets Ratio by Year (2024–2025)
Drugs Made In America Acquisition II Corp. Ordinary Shares working capital to net assets ratio by year from 2024 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Drugs Made In America Acquisition II Cor assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -0.1% | $-274.83K | $487.16 Million | $26.04K | $300.86K | ▼ -167.3 pp |
| 2024 | 167.2% | $-195.17K | $-116.72K | $59.62K | $254.78K | — |